Hemay-601

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameHemay-601
Drug Alias Namethalidomide salt (Tianjin Hemay Bio-Tech)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTNF alpha synthesis inhibitorsImmunomodulators
TargetsUpdating
Therapy Area/IndicationsMyelodysplastic Syndromes
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesTianjin Hemay Bio-Tech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsMyelodysplastic Syndromes

Other Information

ATC CodeN/A
Related LinksN/A